BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29627936)

  • 21. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INVASIVE FUNGAL INFECTION AMONG FEBRILE PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA IN THAILAND.
    Phikulsod P; Suwannawiboon B; Chayakulkeeree M
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):159-69. PubMed ID: 29644832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
    Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
    J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
    Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
    Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geotrichum spp: An overlooked and fatal etiologic agent in immunocompromised patients. A case series from a referral center in Mexico.
    Rajme-López S; González-Lara MF; Martínez-Gamboa RA; Rangel-Cordero A; Ponce-de-León A
    Med Mycol; 2022 Apr; 60(4):. PubMed ID: 35325175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003-2013.
    Wang SS; Kotecha RS; Bernard A; Blyth CC; McMullan BJ; Cann MP; Yeoh DK; Bartlett AW; Ryan AL; Moore AS; Bryant PA; Clark J; Haeusler GM
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27915. PubMed ID: 31309711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive Fungal Infections in Children with Leukemia: Clinical Features and Prognosis.
    Sezgin Evim M; Tüfekçi Ö; Baytan B; Ören H; Çelebi S; Ener B; Üstün Elmas K; Yılmaz Ş; Erdem M; Hacımustafaoğlu MK; Güneş AM
    Turk J Haematol; 2022 Jun; 39(2):94-102. PubMed ID: 34792308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for mortality in patients with pulmonary mucormycosis.
    Son HJ; Song JS; Choi S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Mycoses; 2020 Jul; 63(7):729-736. PubMed ID: 32304253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
    Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.
    Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M
    Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary.
    Szabo BG; Lakatos B; Bobek I; Szabo E; Szlavik J; Vályi-Nagy I
    J Mycol Med; 2021 Dec; 31(4):101198. PubMed ID: 34428666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Invasive Fungal Infection in Children and Adolescents With Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan.
    Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    Pediatr Infect Dis J; 2018 Dec; 37(12):1282-1285. PubMed ID: 30408007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
    Schauwvlieghe AFAD; Rijnders BJA; Philips N; Verwijs R; Vanderbeke L; Van Tienen C; Lagrou K; Verweij PE; Van de Veerdonk FL; Gommers D; Spronk P; Bergmans DCJJ; Hoedemaekers A; Andrinopoulou ER; van den Berg CHSB; Juffermans NP; Hodiamont CJ; Vonk AG; Depuydt P; Boelens J; Wauters J;
    Lancet Respir Med; 2018 Oct; 6(10):782-792. PubMed ID: 30076119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
    Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
    J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical Characteristics and Risk Factors of Invasive Fungal Infections in Acute Leukemia Patients in Tropical Regions].
    Zheng WS; Guan LX; Wang SY; Hu YL; Peng B; Bo J; Wang QS; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):99-106. PubMed ID: 35123610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of invasive fungal infections during hospital construction: how to minimize its impact in immunocompromised patients.
    Alvarez-Moreno CA; Combariza JF
    Curr Opin Infect Dis; 2019 Aug; 32(4):322-329. PubMed ID: 31157630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.